Effects of TrichoS on Hair Growth Promotion in Alopecia X and Other Hair-loss Conditions

Similar documents
LA LUCIA VETERINARY CLINIC 23 Oakleigh Avenue, La Lucia

Therapeutic apheresis in veterinary

HOW XTC IMPROVED MINOXIDIL PENETRATION - 5 WAYS!

Medicine / Pharmaceuticals CATALOGUE

Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs.

Work-up of alopecia. Favrot, C

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Feline Wellness Report

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

Australian Shepherd Pedigree Breed Health Survey

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Transition cows have decreased immune function. The transition period. Inflammation, Immune Function, and the Transition Cow.

LOVE DESERVES LASTING ITCH REL EF. CYTOPOINT has been shown to be effective for the treatment of dogs against allergic and atopic dermatitis.

LOVE DESERVES LASTING ITCH REL EF. CYTOPOINT has been shown to be effective for the treatment of dogs against allergic and atopic dermatitis.

The nutritional solution of dermatological problems

2018 General Health Survey

2018 General Health Survey

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

New Model. Digital Mastitis Detector. Reduce of risk at early stage

Clinical Programme. Dermatology

SUMMARY OF PRODUCT CHARACTERISTICS

APOQUEL 3.6 MG TABLETS FOR DOGS / KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS BEFORE OPENING OR USING

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Unshakeable confidence

Package leaflet: Information for the user

Package leaflet: Information for the user. HYDROCORTISON CUM CHLORAMPHENICOL 5 mg/g + 2 mg/g eye ointment hydrocortisone acetate, chloramphenicol

Restore life and vitality in your dog. Feel the same results as an owner.

Minims Chloramphenicol

Large Munsterlander Pedigree Breed Health Survey

Simplicef is Used to Treat Animals with Skin Infections

CE West June 1-3, 2018 Wine Country Inn, Palisade, CO

Scientific Discussion post-authorisation update for Rheumocam extension X/007

EQUINE CUSHING S DISEASE

Golden Retriever Pedigree Breed Health Survey

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

Guidelines on prescribing antibiotics. For physicians and others in Denmark

Dry Eye Keratoconjunctivitis sicca (KCS)

Restore life and vitality in your dog. Feel the same results as an owner.

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Finnish Lapphund Pedigree Breed Health Survey

Learn how CYTOPOINT can help control itch to bring back the fun in life

RUFF HERO. Glucosamine for Dogs. Pet Parent Manual

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Veterinary Dermatology course rd of May 2015 Veterinary Education Centre, Faculty of Veterinary Medicine, Jegava, Latvia

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

Proceedings of the Southern European Veterinary Conference - SEVC -

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

Veterinary Medical Terminology

Therios 300 mg and 750 mg Palatable Tablets for Dogs

State of the Veterinary Market 2018 TREND ANALYSIS

The Aging Dog. General Information

DECHRA DERMATOLOGY. Why Dechra Dermatology?

Wallenpaupack Veterinary Clinic 2425 Route 6 Hawley, PA Senior Pet Care

Increased incidence of megaesophagus in dogs in Latvia

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS VIRBAGEN OMEGA - EN 1

Clumber Spaniel Pedigree Breed Health Survey

THE ROYAL COLLEGE OF VETERINARY SURGEONS DIPLOMA EXAMINATION IN VETERINARY DERMATOLOGY. Tuesday 22 August PAPER 1 (3 hours)

SUMMARY OF PRODUCT CHARACTERISTICS

Author of PGD: Adrian MacKenzie, Lead Pharmacist, Community Pharmacy.

NUTRITIONAL SUPPLEMENTS FOR PETS

European Society of Veterinary Dermatology

The following part explains the actual status of scientific investigations/knowledge.

5STEPS. Becca Tobin This Glee star plays the part of a bully, but in real life, this avid animal lover is anything but. Allergies.

Synopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets

The OIE Relevant Standards and Guidelines for Veterinary Medicinal Products

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

Claw Health Data Recording in Spanish Dairy Cattle

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

Health Products Regulatory Authority

Mobility Issues and Arthritis

Service Dog Application

OC Lifestyle. Itching for a Solution

SUMMARY OF PRODUCT CHARACTERISTICS

2007 BICHON FRISE BREEDERS HEALTH SURVEY Part 4: Prevalence of Health Conditions

New Zealand Consumer Medicine Information

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

PSPP System for Otitis Externa by Craig Griffin. Treatment T / S AB/AF/GC/EC/AllRx/D/Ot Causes and Factors Cyt/Oto/CR/Ot C LTM LLRx

MEDICAL CENTER POLICY NO.

Irish Medicines Board

Tautopathic Treatment. Systemic infection or localized infections

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

Pesky Ectoparasites. Insecta fleas, lice and flies. Acari- ticks and mites

COALINGA STATE HOSPITAL. NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 705. Effective Date: August 31, 2006

Rapid Diagnostic Test for pet

EPAR type II variation for Metacam

towards a more responsible antibiotics use in asian animal production: supporting digestive health with essential oil compounds TECHNICAL PAPER

Cattle Foot Care And Lameness control

Top 5 ailments in dogs

Natural Goodness... Throughout Life...

A first-line treatment for ear infections in children with ear tubes*

[Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

BSc, PhD, MBA, LLM, MSc (Med Sci), DAgVetPharm, FRPharmS, FCPP, FIPharmM, MPS (NZ), FNZCP, FFHom

SUMMARY OF PRODUCT CHARACTERISTICS. Pharmasin 250 mg/g Premix for medicated feeding stuff for pigs, broilers and pullets

THE VETERINARIAN'S CHOICE. Compendium clinical Trials. Introducing new MILPRO. from Virbac. Go pro. Go MILPRO..

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Unit title: Livestock Husbandry, Health and Welfare (SCQF level 6)

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

Transcription:

Effects of TrichoS on Hair Growth Promotion in Alopecia X and Other Hair-loss Conditions Hiroshi OKAWA, 1,2 Momoko HANAZAWA, 1,2 Akihisa KATO, 3 Hiroyuki INAGAWA, 2,4 Hiroshi KOIE 5 Abstract Background: We have found positive effects on hair growth promotion of the combination preparation containing Pantoea agglomerans lipopolysaccharide (LPS) and Pinus pinaster polyphenol as active ingredients and reported the results in the 36th Annual Meeting of Japanese Society of Clinical Veterinary Medicine. (1,2) We also obtained a patent (Patent No. 6227594). Here we report summarized results of the multicenter clinical study of the product for hair growth in animals. Methods: An oral combination preparation of LPS and Pinus pinaster polyphenol (TrichoS) was given to a total of 273 small animals including 237 dogs, 18 cats, and 8 other animals for approximately 30 days. Hair growth promoting effects were evaluated visually or photographically. Cases of hair growth noted in thinning hair areas were rated as improved. Results and discussion: Of 273 animals, 152 (56%) showed improved hair growth. We consider that LPS may also improve skin conditions from telogen to anagen by promoting production of the vascular endothelial growth factor or fibroblast growth factor. We also consider that the antioxidative effects and blood circulation promoting effects of Pinus pinaster polyphenol may contribute to the hair growth synergistically with LPS. This combination preparation is expected to become a supplement or medicine to improve hair loss in pets by enhancing their natural healing potential. Keywords: Pantoea agglomerans LPS, Pinus pinaster polyphenol, TrichoS Introduction Hair loss or extremely thinning hair owing to skin disorders in pets seriously affects their appearance, potentially causing emotional stress for their owners. Known causative disorders of hair loss include atopic dermatitis, parasitic dermatitis, fungal or bacterial infections, hormonal disorders, stress, and sebaceous gland inflammation. More pets are developing allergies these days possibly because they are kept indoors and are less exposed to lipopolysaccharide (LPS), resulting from improved hygienic environment and increased availability of processed food. At the same time, Stress and lack of physical activity may also cause an increased number of allergic diseases. (3) Based on the above considerations, we studied skin conditions, especially improvement in hair growth, in animals receiving a combination preparation of LPS and Pinus pinaster polyphenol in cooperation with practicing veterinarians. Reportedly, LPS normalizes the immune balance and Pinus pinaster polyphenol has high antioxidative activities.

Materials and Methods A total of 273 animals with hair loss were included in the study, including 237 dogs (mean age, 4.8 years), 18 cats (mean age, 4.9 years) and 8 other animals (mean age, 3.9 years). Oral tablets of the combination preparation of LPS and Pinus pinaster polyphenol (TrichoS, Scarecrow Incorporated) were given at a dose of 0.4 tablet/kg/day for approximately 30 days. The LPS used was an animal food substance (Institute of Applied Technology for Innate Immunity) prepared by hot-water extraction of the cultured Pantoea agglomerans, which had been isolated from wheat. Pinus pinaster polyphenol used was extracted from the cortex of pines growing on the coast of France (Horphag Research). (1) Consumption of pet food or pharmaceutical products was permitted, except for concomitant use of other supplements, in principle. The study animals received the oral combination preparation twice daily for approximately 30 days. Hair growth promoting effects were evaluated visually or photographically by the veterinarians by comparing skin conditions before and after the study supplement consumption. A reduction in hair loss area by 80% or higher was rated as highly improved, 79% or less as alleviated, and 0% as unchanged. Results Of 273 small animals, 152 (56%) had highly improved hair growth. The number of animals with highly improved hair growth was 136 of 237 dogs (57%), 13 of 18 cats (72%), and 3 of 8 other animals (38%). Five dogs, three cats, and two other animals were withdrawn from the study because of difficulty in receiving the study drug. Symptoms and causes of hair loss in the study animals were Alopecia X (28 of 53 animals, or 53%), atopic dermatitis (28 of 47 animals, or 60%), allergic dermatitis (4 of 11 animals, or 36%), other types of hair loss (70 of 118 animals, or 60%), and other types of dermatitis (20 of 35 animals, or 57%). The other types of hair loss included hair loss not associated with itching or inflammation (telogen, 4 of 5 animals, or 80%), hypothyroidism (7 of 14 animals, or 50%), generalized or localized hair loss (27 of 52 animals, or 52%), and hair loss and impaired hair growth due to injury or shaving (1 of 2 animals, or 50%). The other main types of dermatitis included chronic dermatitis (2 of 6 animals, or 33%), pyoderma (8 of 12 animals, or 67%), malasseziosis (3 of 6 animals, or 50%), demodicosis (3 of 3 animals, or 100%), and sore hocks (0 of 3 animals, or 0%). Discussion Healthy animals have normal metabolism, which maintains their biological functions. Phagocytes (macrophages) that reside in all body tissues play a central role in innate immunity, including elimination of foreign substances and tissue repair. For example, impaired action of vascular endothelial growth factor or fibroblast growth factor of macrophages may decrease the regeneration ability of many tissues, such as muscles, bones, and corpus luteum. We have found that LPS may also improve hair growth effects from telogen to anagen by promoting production of the vascular

endothelial growth factor or fibroblast growth factor. We also consider that the study combination preparation showed its effects on hair growth promotion because the effectiveness of LPS was enhanced by antioxidative effects and blood circulation promoting effects of Pinus pinaster polyphenol. We will continue such studies by further accumulating data to determine responsive animals and the hair growth mechanism of LPS in combination with Pinus pinaster polyphenol. Acknowledgments In this study, we had full cooperation from Pet Igaku Organization and many other animal hospitals (Kurihara Animal Hospital, Hiroki Animal Hospital, Arakida Animal Hospital, Ami Animal Hospital, Koshigaya Animal Medical Center, Takahashi Animal Hospital, Oji Pet Clinic, Pet Clinic Clover, Karugamo Animal Hospital, Saito Animal Hospital, Igarashi Animal Hospital, Ogawa Animal Hospital, Nagai Pet Clinic, Abe Animal Hospital, Higashikoganei Pet Clinic, Mukai Cat and Dog Hospital, Maple Animal Hospital, Akikawa Animal Hospital, Okamoto Animal Hospital, Hirano Animal Hospital, Kadoya Animal Hospital, Fuu-Animal Hospital, Terauchi Animal Hospital, Sakura Animal Hospital, and 223 other hospitals).

Summary of Effectiveness of TrichoS by disease 0 animals (0%) Alopecia X 3 animals (6%) 25 animals (47%) 25 animals (47%) 3 animals (6%) 25 animals (47%) 25 animals (47%) 0 animals (0%) 2 animals (6%) Atopic dermatitis 2 animals (5%) 6 animals (17%) 26 animals (72%) 2 animals (5%) 26 animals (72%) 17 animals (17%) 2 animals (6%) 1 animal (9%) Allergic dermatitis 1 animal (9%) 6 animals (55%) 3 animals (27%) 1 animal (9%) 3 animals (27%) 6 animals (55%) 1 animal (9%)

1 animal (1%) Other types of hair loss 8 animals (7%) 47 animals (40%) 8 animals (7%) 62 animals (52%) 47 animals (40%) 62 animals 1 animal (1%) (52%) 0 animals (0%) Other types of dermatitis 1 animal (3%) 15 animals (43%) 19 animals (54%) 1 animal (3%) 19 animals (54%) 15 animals (43%) 0 animals (0%) References (1) The 36th Annual Meeting of Japanese Society of Clinical Veterinary Medicine, Proceedings, No.3, 181 182 (2015) (2) ANTICANCER RESEARCH 36, 3687-3692(2016) (3) ANTICANCER RESEARCH 35, 4501-4508(2015) 1) Scarecrow Corporation: 2F Umeyama Building, 11-8 Shinsen-cho, Shibuya-ku, Tokyo 150-0045 2) Control of Innate Immunity Technology Research Association: Kagawa Bio laboratory, FROM, 2217-16 Hayashimachi, Takamatsu-shi, Kagawa 761-0301 3) Pet Igaku Organization: 4-3-8 Chuo, Ushiku-shi, Ibaraki 300-1234 4) Research Institute for Healthy Living, Niigata University of Pharmacy and Applied Life Sciences: 265 1 Higashijima, Akiha-ku, Niigata-shi, Niigata 5) Laboratory of Veterinary Pathophysiology, Department of Veterinary Medicines, College of

Bioresource Science, Nihon University: 1866 Kameino, Fujisawa-shi, Kanagawa 252-0880